BICYCLE THERAPEUTICS PLC·4

Jul 7, 5:00 PM ET

Thompson Travis Alvin 4

4 · BICYCLE THERAPEUTICS PLC · Filed Jul 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Bicycle Therapeutics (BCYC) CFO Travis Thompson Sells Shares

What Happened

  • Travis (Travis Alvin Thompson), Chief Financial Officer of Bicycle Therapeutics plc (BCYC), sold a total of 923 shares in two open-market transactions to satisfy tax withholding on RSU vesting. He sold 819 shares on 2026-07-02 for a weighted average price of $4.27 (proceeds ~$3,497) and 104 shares on 2026-07-06 for a weighted average price of $4.31 (proceeds ~$448). These were sales (not purchases) and were mandated as "sell-to-cover" for statutory tax withholding rather than discretionary sell orders.

Key Details

  • Transaction dates and prices:
    • 2026-07-02: 819 shares sold, weighted avg $4.27 (prices ranged $4.26–$4.29 per filing) — proceeds ~$3,497. (Footnote F2)
    • 2026-07-06: 104 shares sold, weighted avg $4.31 (prices ranged $4.30–$4.31 per filing) — proceeds ~$448. (Footnote F3)
  • Total shares sold: 923; total reported proceeds: approx. $3,945.
  • Reason/footnote: Footnote F1 states these sales were required to cover statutory tax withholding tied to RSU vesting (a mandated "sell-to-cover"), not discretionary sales.
  • Shares owned after transaction: not specified in the provided filing.
  • Filing timing: Report lists transaction date 2026-07-02 with a filing date of 2026-07-07 (filed 5 days after the first transaction); this appears later than the standard 2-business-day Form 4 reporting window.

Context

  • "Sell-to-cover" transactions are common when restricted stock units vest and typically do not signal a change in an insider's view of the company; they are routine tax-related dispositions rather than voluntary portfolio moves.
  • For retail investors, purchases by insiders tend to carry more forward-looking informational value than routine tax-related sales.

Insider Transaction Report

Form 4
Period: 2026-07-02
Thompson Travis Alvin
Chief Financial Officer
Transactions
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-07-02$4.27/sh819$3,49764,545 total
  • Sale

    Ordinary Shares

    [F1][F3]
    2026-07-06$4.31/sh104$44864,441 total
Footnotes (3)
  • [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive.
Signature
/s/ Travis Thompson|2026-07-07

Documents

1 file
  • 4
    form4-07072026_050702.xmlPrimary